US Stock MarketDetailed Quotes

Cue Biopharma (CUE)

Watchlist
  • 17.6950
  • +1.0690+6.43%
Close Apr 24 16:00 ET
  • 17.6950
  • 0.00000.00%
Post 20:01 ET
57.60MMarket Cap-2.11P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cue Biopharma (CUE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
40.30%-21.69M
88.08%-1.08M
-19.89%-9.02M
65.82%-3.42M
16.48%-8.17M
9.09%-36.33M
17.61%-9.03M
3.49%-7.53M
3.67%-9.99M
9.68%-9.78M
Net income from continuing operations
34.60%-26.6M
116.69%1.59M
14.00%-7.45M
16.61%-8.48M
0.73%-12.26M
19.83%-40.67M
29.31%-9.5M
21.31%-8.66M
22.86%-10.17M
5.81%-12.35M
Operating gains losses
133.33%31K
-600.00%-20K
----
----
----
-159.24%-93K
-97.48%4K
---98K
----
----
Depreciation and amortization
48.09%3.48M
606.72%1.21M
-32.04%596K
-7.66%796K
3.89%882K
-31.61%2.35M
-127.97%-238K
2.45%877K
1.53%862K
-3.52%849K
Other non cash items
0.00%167K
0.00%41K
0.00%43K
2.44%42K
-2.38%41K
0.00%167K
0.00%41K
0.00%43K
0.00%41K
0.00%42K
Change In working capital
33.10%-3.3M
-395.89%-4.47M
-184.36%-3.62M
219.69%2.97M
765.69%1.82M
-427.30%-4.93M
-39.26%-901K
-617.07%-1.27M
-6,095.00%-2.48M
44.42%-274K
-Change in receivables
-963.21%-6.5M
-333.76%-5.16M
111.11%145K
-443.85%-2.43M
217.11%945K
145.89%753K
5,907.89%2.21M
-148.10%-1.31M
52.35%-447K
314.39%298K
-Change in prepaid assets
-95.88%10K
169.93%1.85M
-321.18%-752K
-111.57%-25K
-6.41%-1.06M
872.00%243K
226.19%685K
-54.42%340K
-51.79%216K
27.63%-998K
-Change in payables and accrued expense
127.11%517K
146.71%1.84M
-177.06%-927K
-388.60%-3.22M
89.25%2.82M
-240.43%-1.91M
-12,812.90%-3.94M
1.86%1.2M
-145.85%-658K
215.52%1.49M
-Change in other current liabilities
-29.44%-2.57M
-260.87%-518K
36.44%-504K
2.19%-758K
-6.88%-792K
28.73%-1.99M
144.48%322K
-11.69%-793K
-10.40%-775K
-13.65%-741K
-Change in other working capital
359.00%5.25M
-1,325.86%-2.48M
-145.89%-1.76M
1,276.78%9.58M
73.60%-85K
-195.98%-2.03M
-38.10%-174K
-61.12%-717K
-187.63%-814K
-110.86%-322K
Cash from discontinued investing activities
Operating cash flow
40.30%-21.69M
88.08%-1.08M
-19.89%-9.02M
65.82%-3.42M
16.48%-8.17M
9.09%-36.33M
17.61%-9.03M
3.49%-7.53M
3.67%-9.99M
9.68%-9.78M
Investing cash flow
Cash flow from continuing investing activities
134.38%75K
702,100.00%7.02M
-7,006.12%-6.77M
-170.00%-27K
-172.73%-150K
-99.87%32K
-1K
-98.04%98K
-100.20%-10K
-100.37%-55K
Net PPE purchase and sale
-528.13%-137K
2,100.00%20K
-79.59%20K
-170.00%-27K
-172.73%-150K
1,500.00%32K
---1K
--98K
---10K
-2,850.00%-55K
Net investment purchase and sale
--212K
--7M
----
----
----
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
134.38%75K
702,100.00%7.02M
-7,006.12%-6.77M
-170.00%-27K
-172.73%-150K
-99.87%32K
---1K
-98.04%98K
-100.20%-10K
-100.37%-55K
Financing cash flow
Cash flow from continuing financing activities
156.67%26.29M
1,118.45%9.49M
-99.99%1K
1,879.80%17.8M
-142.48%-1M
-13.63%10.24M
-119.49%-932K
114.01%9.82M
-147.60%-1M
506.70%2.35M
Net issuance payments of debt
-12.53%-4.5M
-50.15%-1.5M
0.00%-1M
0.00%-1M
0.00%-1M
-99.95%-4M
0.10%-999K
0.00%-1M
---1M
---1M
Net common stock issuance
116.47%30.79M
22,332.65%10.99M
-90.75%1M
--18.8M
--0
6.25%14.22M
-99.15%49K
93.61%10.82M
--0
--3.35M
Proceeds from stock option exercised by employees
--0
----
----
----
----
-96.19%18K
--18K
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
156.67%26.29M
1,118.45%9.49M
-99.99%1K
1,879.80%17.8M
-142.48%-1M
-13.63%10.24M
-119.49%-932K
114.01%9.82M
-147.60%-1M
506.70%2.35M
Net cash flow
Beginning cash position
-53.54%22.61M
-63.61%11.85M
-8.40%27.65M
-67.73%13.29M
-53.54%22.61M
-5.99%48.67M
-40.61%32.57M
-43.11%30.18M
-26.88%41.18M
-5.99%48.67M
Current changes in cash
117.96%4.68M
254.96%15.44M
-760.16%-15.79M
230.51%14.36M
-24.54%-9.32M
-740.72%-26.05M
-61.29%-9.96M
33.63%2.39M
-236.39%-11M
-264.25%-7.49M
End cash Position
20.69%27.29M
20.69%27.29M
-63.61%11.85M
-8.40%27.65M
-67.73%13.29M
-53.54%22.61M
-53.54%22.61M
-40.61%32.57M
-43.11%30.18M
-26.88%41.18M
Free cash flow
39.93%-21.86M
88.08%-1.08M
-19.90%-9.02M
65.58%-3.44M
15.42%-8.32M
8.92%-36.4M
17.59%-9.03M
3.50%-7.53M
3.58%-10M
9.18%-9.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 40.30%-21.69M88.08%-1.08M-19.89%-9.02M65.82%-3.42M16.48%-8.17M9.09%-36.33M17.61%-9.03M3.49%-7.53M3.67%-9.99M9.68%-9.78M
Net income from continuing operations 34.60%-26.6M116.69%1.59M14.00%-7.45M16.61%-8.48M0.73%-12.26M19.83%-40.67M29.31%-9.5M21.31%-8.66M22.86%-10.17M5.81%-12.35M
Operating gains losses 133.33%31K-600.00%-20K-------------159.24%-93K-97.48%4K---98K--------
Depreciation and amortization 48.09%3.48M606.72%1.21M-32.04%596K-7.66%796K3.89%882K-31.61%2.35M-127.97%-238K2.45%877K1.53%862K-3.52%849K
Other non cash items 0.00%167K0.00%41K0.00%43K2.44%42K-2.38%41K0.00%167K0.00%41K0.00%43K0.00%41K0.00%42K
Change In working capital 33.10%-3.3M-395.89%-4.47M-184.36%-3.62M219.69%2.97M765.69%1.82M-427.30%-4.93M-39.26%-901K-617.07%-1.27M-6,095.00%-2.48M44.42%-274K
-Change in receivables -963.21%-6.5M-333.76%-5.16M111.11%145K-443.85%-2.43M217.11%945K145.89%753K5,907.89%2.21M-148.10%-1.31M52.35%-447K314.39%298K
-Change in prepaid assets -95.88%10K169.93%1.85M-321.18%-752K-111.57%-25K-6.41%-1.06M872.00%243K226.19%685K-54.42%340K-51.79%216K27.63%-998K
-Change in payables and accrued expense 127.11%517K146.71%1.84M-177.06%-927K-388.60%-3.22M89.25%2.82M-240.43%-1.91M-12,812.90%-3.94M1.86%1.2M-145.85%-658K215.52%1.49M
-Change in other current liabilities -29.44%-2.57M-260.87%-518K36.44%-504K2.19%-758K-6.88%-792K28.73%-1.99M144.48%322K-11.69%-793K-10.40%-775K-13.65%-741K
-Change in other working capital 359.00%5.25M-1,325.86%-2.48M-145.89%-1.76M1,276.78%9.58M73.60%-85K-195.98%-2.03M-38.10%-174K-61.12%-717K-187.63%-814K-110.86%-322K
Cash from discontinued investing activities
Operating cash flow 40.30%-21.69M88.08%-1.08M-19.89%-9.02M65.82%-3.42M16.48%-8.17M9.09%-36.33M17.61%-9.03M3.49%-7.53M3.67%-9.99M9.68%-9.78M
Investing cash flow
Cash flow from continuing investing activities 134.38%75K702,100.00%7.02M-7,006.12%-6.77M-170.00%-27K-172.73%-150K-99.87%32K-1K-98.04%98K-100.20%-10K-100.37%-55K
Net PPE purchase and sale -528.13%-137K2,100.00%20K-79.59%20K-170.00%-27K-172.73%-150K1,500.00%32K---1K--98K---10K-2,850.00%-55K
Net investment purchase and sale --212K--7M--------------0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow 134.38%75K702,100.00%7.02M-7,006.12%-6.77M-170.00%-27K-172.73%-150K-99.87%32K---1K-98.04%98K-100.20%-10K-100.37%-55K
Financing cash flow
Cash flow from continuing financing activities 156.67%26.29M1,118.45%9.49M-99.99%1K1,879.80%17.8M-142.48%-1M-13.63%10.24M-119.49%-932K114.01%9.82M-147.60%-1M506.70%2.35M
Net issuance payments of debt -12.53%-4.5M-50.15%-1.5M0.00%-1M0.00%-1M0.00%-1M-99.95%-4M0.10%-999K0.00%-1M---1M---1M
Net common stock issuance 116.47%30.79M22,332.65%10.99M-90.75%1M--18.8M--06.25%14.22M-99.15%49K93.61%10.82M--0--3.35M
Proceeds from stock option exercised by employees --0-----------------96.19%18K--18K--0--0--0
Cash from discontinued financing activities
Financing cash flow 156.67%26.29M1,118.45%9.49M-99.99%1K1,879.80%17.8M-142.48%-1M-13.63%10.24M-119.49%-932K114.01%9.82M-147.60%-1M506.70%2.35M
Net cash flow
Beginning cash position -53.54%22.61M-63.61%11.85M-8.40%27.65M-67.73%13.29M-53.54%22.61M-5.99%48.67M-40.61%32.57M-43.11%30.18M-26.88%41.18M-5.99%48.67M
Current changes in cash 117.96%4.68M254.96%15.44M-760.16%-15.79M230.51%14.36M-24.54%-9.32M-740.72%-26.05M-61.29%-9.96M33.63%2.39M-236.39%-11M-264.25%-7.49M
End cash Position 20.69%27.29M20.69%27.29M-63.61%11.85M-8.40%27.65M-67.73%13.29M-53.54%22.61M-53.54%22.61M-40.61%32.57M-43.11%30.18M-26.88%41.18M
Free cash flow 39.93%-21.86M88.08%-1.08M-19.90%-9.02M65.58%-3.44M15.42%-8.32M8.92%-36.4M17.59%-9.03M3.50%-7.53M3.58%-10M9.18%-9.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -